國藥科技股份(08156.HK)子公司向權星智控訂購兩台口罩生產線 每年總產能超5億個
格隆匯2月21日丨國藥科技股份(08156.HK)公佈,公司已透過其直接持股全資子公司—國藥科技企業管理有限公司與權星智控系統工程(上海)股份有限公司訂立一份訂購合同。
根據訂購合同,國藥科技企業管理將向權星智控訂購兩台醫用一次性口罩全自動化生產線,預計設備將不遲於3月12日交付。
公告顯示,集團最近已訂購十台生產線設備,現再增購兩台生產線設備,共十二條生產線將於短期內投入廠房交付使用。其中四條生產線計劃放置香港,用於組建新生產線,產能為每天48萬個口罩,年產能約1.75億個。餘下八條生產線的產能為每天96萬個口罩,年產能約3.5億個,這些生產線可為內地及香港供應的口罩產能總和每年可超過5億個。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.